Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

NCT07527143 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07527143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2026
Completion date
June 10, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma